Literature DB >> 19321402

Investigation of the validity of UICC stage grouping of anaplastic carcinoma of the thyroid.

Yasuhiro Ito1, Takuya Higashiyama, Mitsuyoshi Hirokawa, Mitsuhiro Fukushima, Hiroyuki Inoue, Tomonori Yabuta, Chisato Tomoda, Takashi Uruno, Minoru Kihara, Yuuki Takamura, Akihiro Miya, Kaoru Kobayashi, Fumio Matsuzuka, Akira Miyauchi.   

Abstract

OBJECTIVE: Anaplastic thyroid carcinoma arises from differentiated carcinoma and has a very aggressive character. In this study, we investigated the prognosis of patients with anaplastic carcinoma based on UICC stage. PATIENTS AND METHODS: We investigated the prognosis of 75 patients who were diagnosed as having anaplastic carcinoma at Kuma Hospital between 1983 and 2006. Of these patients, 14, 49 and 12 were classified into Stages IVA, IVB, and IVC respectively.
RESULTS: Stage IVA patients showed a significantly better prognosis than Stage IVB or IVC patients (p = 0.0017). All patients with Stage IVC died of carcinoma within 1 year regardless of whether locally complete resection was performed. Prognosis of Stage IVB patients who underwent curative surgery did not differ from that of Stage IVA patients, but the prognosis of those who did not undergo surgery or only received palliative surgery was as poor as that of Stage IVC patients.
CONCLUSIONS: Extensive surgical treatment is recommended for Stage IVA patients and palliative care is appropriate for Stage IVC patients. For Stage IVB patients, surgical treatment as a primary therapy is appropriate only when curative resection of the tumour is expected.

Entities:  

Mesh:

Year:  2009        PMID: 19321402     DOI: 10.1016/S1015-9584(09)60008-7

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  6 in total

1.  Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients.

Authors:  Iwao Sugitani; Akira Miyauchi; Kiminori Sugino; Takahiro Okamoto; Akira Yoshida; Shinichi Suzuki
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

2.  Influence of risk grouping on therapeutic decisions in patients with anaplastic thyroid carcinoma.

Authors:  Chuanzheng Sun; Chao Li; Zedong Hu; Xiaojiang Li; Jiehua He; Ming Song; Guojun Li; Fenghua Zhang; Qiuli Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-10       Impact factor: 2.503

3.  Enlarging neck masses in the elderly - Histological and surgical considerations.

Authors:  M D O'Sullivan; K S McAnena; C Egan; P S Waters; P J McCann; M J Kerin
Journal:  Int J Surg Case Rep       Date:  2013-01-17

4.  Biological behavior of papillary carcinoma of the thyroid including squamous cell carcinoma components and prognosis of patients who underwent locally curative surgery.

Authors:  Yasuhiro Ito; Mitsuyoshi Hirokawa; Takuya Higashiyama; Minoru Kihara; Chisato Tomoda; Yuuki Takamura; Kaoru Kobayashi; Akihiro Miya; Akira Miyauchi
Journal:  J Thyroid Res       Date:  2011-09-18

5.  Lenvatinib for Anaplastic Thyroid Cancer and Lenvatinib-Induced Thyroid Dysfunction.

Authors:  Satoshi Koyama; Naritomo Miyake; Kazunori Fujiwara; Tsuyoshi Morisaki; Takahiro Fukuhara; Hiroya Kitano; Hiromi Takeuchi
Journal:  Eur Thyroid J       Date:  2018-02-21

6.  Treatment and prognosis of anaplastic thyroid carcinoma: experience from a single institution in China.

Authors:  Chuanzheng Sun; Qiuli Li; Zedong Hu; Jiehua He; Chao Li; Guojun Li; Xiaofeng Tao; Ankui Yang
Journal:  PLoS One       Date:  2013-11-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.